Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2017 Publisher: Teva Pharma (New Zealand) Limited, PO Box 128 244, Remuera, Auckland 1541, Telephone: 0800 800 097
Arrow – Roxithromycin 150, 150 mg, coated tablets.
Arrow – Roxithromycin 300, 300 mg, coated tablets.
| Pharmaceutical Form |
|---|
|
White, round, coated tablets. |
Each tablet contains 150 mg or 300 mg of roxithromycin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Roxithromycin |
Roxithromycin is a semi-synthetic macrolide antibiotic. Roxithromycin is bacteriostatic at low concentrations and bactericidal at high concentrations. It binds to the 50S subunit of the 70S ribosome, thereby disrupting bacterial protein synthesis. |
| List of Excipients |
|---|
|
Low substituted hydroxypropyl cellulose (hyprolose) |
PVC/PVdC/Aluminium foil blister strips. Pack size of 10 tablets (150 mg) and 5 tablets (300 mg).
Teva Pharma (New Zealand) Limited, PO Box 128 244, Remuera, Auckland 1541, Telephone: 0800 800 097
28 September 2006
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
